Hospital
Sparrow Ionia Hospital
Sparrow Ionia Hospital was paid $13.76M by Medicaid between Jan 2018 and Dec 2024, across 157 billing codes. Its largest line is 99285, emergency room visit (most serious) — 28% of everything it billed.
33Billing provider infoSPARROW IONIA HOSPITAL
IONIA, MI 48846
IONIA, MI 48846
33aNPI1700820065assigned 06/16/2006
33bProvider typeCritical Access Hospital
28Total paid$13.76M
24GClaims321,973
24DCodes billed157
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#4 of 31
Median peer was paid$6.03M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,356 | $1.32M | |
| 2019 | 45,339 | $1.30M | |
| 2020 | 40,958 | $1.78M | |
| 2021 | 54,218 | $2.58M | |
| 2022 | 52,639 | $2.49M | |
| 2023 | 49,116 | $2.26M | |
| 2024incomplete | 40,347 | $2.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28% | 10,985 | 10,031 | $3.89M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 10,829 | 10,117 | $2.40M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 12,870 | 12,267 | $1.95M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.0% | 7,004 | 6,241 | $820K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 2,884 | 2,794 | $454K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 3,965 | 3,490 | $441K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.7% | 7,169 | 6,799 | $377K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.1% | 7,084 | 5,922 | $288K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 9,236 | 2,947 | $279K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 2,256 | 2,180 | $251K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 2,852 | 2,776 | $250K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 5,039 | 4,857 | $215K |
145 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 5,481 | $206K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 1,531 | $150K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,154 | $134K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 973 | $120K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,109 | $104K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,381 | $103K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 830 | $88K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,194 | $84K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 969 | $71K |
| 76830 | Ultrasound, transvaginal | <1% | 925 | $66K |
| 80061 | Lipid panel | <1% | 4,572 | $56K |
| 80053 | Comprehensive metabolic panel | <1% | 25,195 | $47K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,090 | $45K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 171 | $41K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,653 | $40K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 216 | $39K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,345 | $36K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 527 | $34K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,383 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,399 | $29K |
| 97162 | <1% | 645 | $28K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,971 | $28K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,001 | $27K |
| 87631 | <1% | 301 | $24K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,477 | $22K |
| 73030 | <1% | 921 | $21K | |
| 73630 | <1% | 1,525 | $20K | |
| G0378 | Hospital observation service, per hour | <1% | 649 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,674 | $19K |
| 73610 | <1% | 1,067 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,304 | $18K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 164 | $15K |
| 93971 | <1% | 237 | $15K | |
| 73110 | <1% | 718 | $15K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 254 | $15K |
| 73130 | <1% | 1,098 | $15K | |
| 72110 | <1% | 400 | $14K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 374 | $14K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 27 | $14K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 215 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,672 | $12K |
| 73562 | <1% | 470 | $12K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 62 | $11K |
| 93976 | <1% | 177 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 120 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,501 | $10K |
| 82607 | <1% | 1,338 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,065 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 733 | $8K |
| 86900 | <1% | 676 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 699 | $8K |
| 97161 | <1% | 103 | $7K | |
| 82728 | <1% | 1,152 | $7K | |
| 86803 | <1% | 936 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 282 | $7K |
| 85027 | <1% | 3,026 | $6K | |
| 84439 | <1% | 1,622 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 271 | $6K |
| 96367 | <1% | 129 | $6K | |
| 83550 | <1% | 1,389 | $6K | |
| 74022 | <1% | 245 | $5K | |
| 73564 | <1% | 337 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,552 | $5K |
| 83540 | <1% | 1,530 | $4K | |
| 87077 | <1% | 1,990 | $4K | |
| 83880 | <1% | 2,213 | $4K | |
| 73502 | <1% | 159 | $4K | |
| 83735 | <1% | 5,694 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 486 | $3K |
| 87186 | <1% | 1,636 | $3K | |
| 70498 | <1% | 12 | $3K | |
| 85610 | <1% | 3,314 | $3K | |
| 82652 | <1% | 141 | $3K | |
| 86780 | <1% | 336 | $2K | |
| 84702 | <1% | 555 | $2K | |
| 82043 | <1% | 902 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 284 | $2K |
| 86140 | <1% | 6,474 | $2K | |
| 76801 | <1% | 28 | $2K | |
| 81001 | <1% | 7,855 | $2K | |
| 82570 | <1% | 489 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 75 | $1K |
| 85652 | <1% | 1,399 | $1K | |
| 87210 | <1% | 721 | $1K | |
| 73090 | <1% | 70 | $933.81 | |
| 83690 | <1% | 4,571 | $840.03 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 43 | $671.22 |
| 86850 | <1% | 457 | $636.09 | |
| 80074 | <1% | 24 | $613.30 | |
| 93017 | <1% | 13 | $567.80 | |
| 74019 | <1% | 18 | $560.65 | |
| 87563 | <1% | 28 | $556.27 | |
| 74018 | <1% | 56 | $541.42 | |
| 84703 | <1% | 6,074 | $530.97 | |
| 81003 | <1% | 3,998 | $484.46 | |
| 76642 | <1% | 12 | $471.91 | |
| 85730 | <1% | 2,147 | $465.67 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,659 | $396.80 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 405 | $368.34 |
| 85379 | <1% | 1,763 | $322.58 | |
| 97035 | <1% | 72 | $322.40 | |
| 87070 | <1% | 99 | $271.08 | |
| 87486 | <1% | 12 | $266.20 | |
| 87581 | <1% | 12 | $266.20 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,121 | $242.45 |
| 84484 | <1% | 5,115 | $235.62 | |
| 86901 | <1% | 651 | $230.20 | |
| 73590 | <1% | 52 | $203.84 | |
| 83605 | <1% | 5,321 | $176.10 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,277 | $169.85 |
| 82550 | <1% | 278 | $165.50 | |
| 12001 | <1% | 14 | $157.91 | |
| 87040 | <1% | 926 | $141.36 | |
| 87340 | <1% | 27 | $136.07 | |
| 73080 | <1% | 16 | $131.02 | |
| 84481 | <1% | 12 | $101.78 | |
| 87420 | <1% | 489 | $100.71 | |
| 85007 | <1% | 190 | $88.22 | |
| 82746 | <1% | 13 | $86.77 | |
| 73070 | <1% | 15 | $79.09 | |
| 87205 | <1% | 56 | $49.40 | |
| 82962 | <1% | 1,072 | $19.69 | |
| 80076 | <1% | 13 | $13.77 | |
| 82948 | <1% | 270 | $3.85 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 103 | $1.15 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,191 | $0.98 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 4,776 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 58 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 910 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,051 | $0.00 |
| 90715 | 0% | 187 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 154 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 321 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 436 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 130 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 287 | $0.00 |
| 96376 | 0% | 1,298 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 231 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 90 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 28 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 15 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 24 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 52 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 14 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSSIAN, MISTY (SUPERVISOR, PROVIDER ENROLLMENT)
Parent organizationSPARROW HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Edward W Sparrow Hospital Association | Lansing, MI | $125.88M |
| Metropolitan Hospital | Wyoming, MI | $100.96M |
| Sparrow Eaton Hospital | Charlotte, MI | $13.22M |
| Sparrow Clinton Hospital | Saint Johns, MI | $8.68M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $5.81M |
| Sparrow Carson Hospital | Carson City, MI | $5.48M |
| Edward W. Sparrow Hospital Association | East Lansing, MI | $5.43M |
| Sparrow Ionia Hospital | Ionia, MI | $3.49M |
| Sparrow Eaton Hospital | Charlotte, MI | $3.12M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.77M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.61M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.48M |
| Edward W. Sparrow Hospital Association | Mason, MI | $2.44M |
| Sparrow Community Care | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $1.85M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.83M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.65M |
| Sparrow Ionia Hospital | Portland, MI | $1.61M |
| Sparrow Carson Hospital | Ithaca, MI | $1.54M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.